A landmark decision was made today in government which will advance women’s health across the UK.
Maxwellia’s Lovima, a new progestogen-only contraceptive pill, is now available to buy in pharmacies. This will be the first time this is available over the counter (OTC) in UK history.
As Lovima confirmed its MHRA status, health officials have already publicly praised the decision. This safe, convenient and reliable treatment will help create wider contraception access, increase individual’s control over their own decisions and reduce pressure on GP services.
The news was created a media storm, with coverage from major titles such as The Times, The Mirror, BBC News, ITV, Sky News, The Times, Evening Standard and The Guardian.
